Publications by authors named "Mark Lesley"

Claim this Profile
P
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
Ruth Plummer, Laura Vidal, Melanie Griffin, Mark Lesley, Johann de Bono

Clin Cancer Resยท May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis